Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Vaccines as a remedy for antimicrobial resistant bacterial infections

Publikacje

SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly

Autorzy: Onnis, A. et al.
Opublikowane w: Journal of Experimental Medicine 220, e20220906, Numer e20220906, 2022, ISSN 0022-1007
Wydawca: Rockefeller University Press
DOI: 10.1084/jem.20220906

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Autorzy: Torres Jonathan, L. et al.
Opublikowane w: Proceedings of the National Academy of Sciences 119, 2022, ISSN 0027-8424
Wydawca: National Academy of Sciences
DOI: 10.1073/pnas.2120976119

Antimicrobial Resistance: A Tale of Nasty Enemies and Powerful Weapons

Autorzy: Fabiola Vacca, Dario Cardamone, Marco Troisi, Claudia Sala, Rino Rappuoli
Opublikowane w: Frontiers for Young Minds, Numer 8, 2020, ISSN 2296-6846
Wydawca: Frontiers Media S.A.
DOI: 10.3389/frym.2020.554493

Antibodies, epicenter of SARS-CoV-2 immunology

Autorzy: Simone Pecetta, Mariagrazia Pizza, Claudia Sala, Emanuele Andreano, Piero Pileri, Marco Troisi, Elisa Pantano, Noemi Manganaro, Rino Rappuoli
Opublikowane w: Cell Death & Differentiation, Numer 28/2, 2021, Strona(/y) 821-824, ISSN 1350-9047
Wydawca: Nature Publishing Group
DOI: 10.1038/s41418-020-00711-w

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

Autorzy: Andreano, E. et al.
Opublikowane w: Nature 600, pages530–535 (2021), Numer Nature 600, pages530–535, 2021, ISSN 0028-0836
Wydawca: Nature Publishing Group
DOI: 10.1038/s41586-021-04117-7

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Autorzy: Emanuele Andreano, Emanuele Nicastri, Ida Paciello, Piero Pileri, Noemi Manganaro, Giulia Piccini, Alessandro Manenti, Elisa Pantano, Anna Kabanova, Marco Troisi, Fabiola Vacca, Dario Cardamone, Concetta De Santi, Jonathan L. Torres, Gabriel Ozorowski, Linda Benincasa, Hyesun Jang, Cecilia Di Genova, Lorenzo Depau, Jlenia Brunetti, Chiara Agrati, Maria Rosaria Capobianchi, Concetta Castilletti, Ar
Opublikowane w: Cell, Numer 184/7, 2021, Strona(/y) 1821-1835.e16, ISSN 0092-8674
Wydawca: Cell Press
DOI: 10.1016/j.cell.2021.02.035

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Autorzy: Andreano, E. & Rappuoli, R.
Opublikowane w: Nature Medicine 27, 759-761, Numer Nature Medicine 27, 759-761, 2021, ISSN 1078-8956
Wydawca: Nature Publishing Group
DOI: 10.1038/s41591-021-01347-0

A new dawn for monoclonal antibodies against antimicrobial resistant bacteria

Autorzy: Troisi, M. et al.
Opublikowane w: Frontiers in Microbiology 13, Numer Frontiers in Microbiology 13, 2022, ISSN 1664-302X
Wydawca: Frontiers Media
DOI: 10.3389/fmicb.2022.1080059

Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana

Autorzy: Frigerio, R. et al.
Opublikowane w: Frontiers in Plant Science 13, Numer Frontiers in Plant Science 13, 2022, ISSN 1664-462X
Wydawca: Frontiers Media S. A.
DOI: 10.3389/fpls.2022.956741

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response

Autorzy: Andreano, E. et al.
Opublikowane w: Nature Communications, Numer 14, Article number: 53 (2023), 2023, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-022-35781-6

High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae

Autorzy: S. Stazzoni et al.
Opublikowane w: Front. Microbiol. Sec. Antimicrobials, Resistance and Chemotherapy, Numer Front. Microbiol., Sec. Antimicrobials, Resistance and Chemotherapy Volume 14 – 2023, 2023, ISSN 1664-302X
Wydawca: Frontiers Media
DOI: 10.3389/fmicb.2023.1243427

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

Autorzy: Lanini, S. et al.
Opublikowane w: Nature Communications 13, 2263, 2022, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-022-29909-x

Vaccines as remedy for antimicrobial resistance and emerging infections

Autorzy: Marco Troisi, Emanuele Andreano, Claudia Sala, Anna Kabanova, Rino Rappuoli
Opublikowane w: Current Opinion in Immunology, Numer 65, 2020, Strona(/y) 102-106, ISSN 0952-7915
Wydawca: Elsevier BV
DOI: 10.1016/j.coi.2020.09.003

Immunodominant antibody germlines in COVID-19

Autorzy: Andreano, E. & Rappuoli, R.
Opublikowane w: Journal of Experimental Medicine 218, Numer Journal of Experimental Medicine 218, 2021, ISSN 0022-1007
Wydawca: Rockefeller University Press
DOI: 10.1084/jem.20210281

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections

Autorzy: Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, Claudia Sala, Rino Rappuoli
Opublikowane w: Biomedicines. 2022 Aug 2;10(8):1861, Numer Biomedicines. 2022 Aug 2;10(8):1861, 2022, ISSN 0753-3322
Wydawca: Elsevier Masson
DOI: 10.3390/biomedicines10081861

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions

Autorzy: Fabiola Vacca, Claudia Sala, Rino Rappuoli
Opublikowane w: Biomedicines 30;10(9):2126, Numer Biomedicines 30;10(9):2126, 2022, ISSN 0753-3322
Wydawca: Elsevier Masson
DOI: 10.3390/biomedicines10092126

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Autorzy: Emanuele Andreano, Giulia Piccini, Danilo Licastro, Lorenzo Casalino, Nicole V. Johnson, Ida Paciello, Simeone Dal Monego, Elisa Pantano, Noemi Manganaro, Alessandro Manenti, Rachele Manna, Elisa Casa, Inesa Hyseni, Linda Benincasa, Emanuele Montomoli, Rommie E. Amaro, Jason S. McLellan, Rino Rappuoli
Opublikowane w: Proceedings of the National Academy of Sciences, Numer 118/36, 2021, Strona(/y) e2103154118, ISSN 0027-8424
Wydawca: National Academy of Sciences
DOI: 10.1073/pnas.2103154118

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees

Autorzy: Andreano, E. et al.
Opublikowane w: Nature Communications 13, 3375, Numer Nature Communications 13, 3375, 2022, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-022-31115-8

High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies

Autorzy: Paciello, I., Maccari, G., Pantano, E., Andreano & Rappuoli, R
Opublikowane w: Proceedings of the National Academy of Sciences 121, e2314730121 (2024), Numer 121, e2314730121 (2024), 2024, ISSN 0027-8424
Wydawca: National Academy of Sciences
DOI: 10.1073/pnas.2314730121

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5

Autorzy: Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giuseppe Maccari, Giada Antonelli, Valentina Abbiento, Piero Pileri, Linda Benincasa, Ginevra Giglioli, Giulia Piccini, Concetta De Santi, Claudia Sala, Duccio Medini, Emanuele Montomoli, Piet Maes & Rino Rappuoli
Opublikowane w: Nature Communication, Numer (2023) 14:1734, 2023, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-023-37422-y

Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens

Autorzy: Troisi, M., et al.
Opublikowane w: COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv, Numer 2023.2012.2007.570438, 2023, ISSN 2692-8205
Wydawca: bioRxiv
DOI: 10.1101/2023.12.07.570438

Wyszukiwanie danych OpenAIRE...

Podczas wyszukiwania danych OpenAIRE wystąpił błąd

Brak wyników